Spondyloarthritis: How JAK inhibitor and TNF inhibitor drugs are helping in SpA

Speciality: Orthopedics


Speaker:

Dr. Jyotsna Oak | MD (Medicine) Consultant, Internal Medicine & Rheumatology

Dr. Shashank Akerkar | MD FACR Consultant Rheumatologist

Dr. Sourabh Malviya | MD FACR, Senior Consultant and Head Rheumatologist

Description:

A warm welcome to all the medical professionals in this interesting session on use of JAK inhibitor and TNF inhibitor drugs in spondyloarthritis. We have Dr. Jyotsna Oak, Dr. Shashank Akerkar and Dr. Sourabh Malviya to lead the session.

Spondyloarthritis is a type of arthritis where the spine is affected and, in some cases, the joints of the arms and legs are also affected. It can also involve the skin, intestines and eyes. The primary symptom observed in most patients is low back pain, mostly axial spondyloarthritis. 

It is thought that spondyloarthritis develops through the interaction of genetic and environmental factors. Further, spondyloarthropathies (SpA) is recognised as autoimmune disease as it is strongly associated with HLA-B27, a gene variant that controls immune responses. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot